Table 3.
KEGG pathway analysis for the differentially expressed genes in ceRNA network (P < 0.01).
KEGG pathway | KEGG entry | Count | Ratio | P-value |
---|---|---|---|---|
Wnt signaling pathway | hsa04310 | 4 | 0.027972 | 0.000340 |
Hepatitis B | hsa05161 | 4 | 0.027397 | 0.000367 |
PI3K-Akt signaling pathway | hsa04151 | 4 | 0.011696 | 0.007647 |
Hedgehog signaling pathway | hsa04340 | 3 | 0.063830 | 0.000196 |
p53 signaling pathway | hsa04115 | 3 | 0.043478 | 0.000575 |
Melanoma | hsa05218 | 3 | 0.042254 | 0.000622 |
TGF-beta signaling pathway | hsa04350 | 3 | 0.035714 | 0.000997 |
NF-kappa B signaling pathway | hsa04064 | 3 | 0.032258 | 0.001324 |
Endocrine resistance | hsa01522 | 3 | 0.030928 | 0.001489 |
AGE-RAGE signaling pathway in diabetic complications | hsa04933 | 3 | 0.029703 | 0.001666 |
FoxO signaling pathway | hsa04068 | 3 | 0.022388 | 0.003638 |
Signaling pathways regulating pluripotency of stem cells | hsa04550 | 3 | 0.021127 | 0.004264 |
Hippo signaling pathway | hsa04390 | 3 | 0.019481 | 0.005318 |
Axon guidance | hsa04360 | 3 | 0.017045 | 0.007628 |
Focal adhesion | hsa04510 | 3 | 0.014778 | 0.011163 |
Butanoate metabolism | hsa00650 | 2 | 0.071429 | 0.002060 |
Basal cell carcinoma | hsa05217 | 2 | 0.036364 | 0.007268 |
Glioma | hsa05214 | 2 | 0.030769 | 0.009925 |